MarCom Awards 2024 update: Our client work landed us four!
We couldn’t be more excited to be recognized for creating standout work for our clients across four diverse segments: radiopharmaceuticals, digital health, biotech, and revenue cycle management.
We’re all about delivering the kind of work that makes our clients shine, and we’re beyond proud to partner with them to bring their big ideas to life.
What are radiopharmaceuticals? A comprehensive introduction
Our content team wrote this in-depth guide to educate pharmaceutical industry professionals about the science behind radiopharmaceuticals and explain how they target and treat cancer compared to traditional diagnostic and treatment methods. We also collaborated with Nucleus RadioPharma’s Chief Scientific Officer, Dr. Geoff Johnson, to provide deep insights into the anatomy and application of these novel therapies.
More about Nucleus RadioPharma: Nucleus RadioPharma is a radiopharmaceutical CDMO building robust and reliable clinical and commercial supply chains for targeted radiotherapies and leading innovators through the complexities of developing, manufacturing, and delivering these therapies.
From data to decisions – Xealth’s blueprint for health system success
We wrote and designed this 2024 Trends white paper to illustrate the opportunities and challenges health systems face as digital health transforms traditional patient care. It includes actionable insights that key decision-makers should consider when evaluating vendor solutions.
More about Xealth: Xealth’s platform integrates digital health vendors, programs, and tools into clinical and patient workflows. With Xealth’s custom data and analytics, health systems can track, analyze, and evaluate everything through their own digital health integration platform.
We Speak Antibody: Infinity Bio’s website
We helped Infinity Bio breathe new life into its brand and create a biotech web that features designs as cutting-edge as its technology platform. Their new search engine optimized (SEO) website clearly articulates this growing biotechnology company’s product offerings and unique technology for antibody profiling in a well-organized, visually appealing manner.
More about Infinity Bio: Infinity Bio, Inc., is a technology company that provides detailed insights into the immune system using its proprietary antibody reactome profiling platform. The company’s core technology, MIPSA, is used to comprehensively analyze the antibody reactome, revealing the targets of individual immune responses against all known human viruses, human proteins (autoimmunity), and allergen proteins.
Tech Target: Generative AI’s potential shines on revenue cycle management
Our public relations team secured a media mention for our client SYNERGEN Health in TechTarget’s article, Generative AI’s Potential Shines on Revenue Cycle Management. The feature highlights SYNERGEN’s position as a thought leader in the industry, with insights from their Chief Product Officer, Sunil Konda, on how generative AI can transform front-end processes and reduce claim denials by improving data accuracy.
More about SYNERGEN Health: SYNERGEN Health provides tech-enabled comprehensive specialty-specific healthcare revenue cycle management services that deliver end-to-end visibility in near real-time across the entire revenue cycle.
Congratulations to all the 2024 MarCom Award winners! We’re proud to stand alongside such talented organizations making an impact in the marketing world.
If you’re looking to elevate your brand with award-winning content, partner with a healthcare tech marketing agency that knows how to deliver results.
